… to investigate if Gleevec has a potential role in treatment of non-small cell lung cancer. …
culture condition is unlikely to be translated to clinical patients, since the adverse effects of the …

… The negative effect on angiogenesis proteins lends support to earlier … cell lung cancer cells
H-460 (large cell carcinoma), A549 (adenocarcinoma) and SKMES1 (squamous carcinoma) …

… of LY294002 and chemotherapy on NSCLC apoptosis were specific for inhibiting Akt/PKB
activity, we transiently cotransfected NSCLC cell lines with HA-tagged dominant negative Akt/…

… cell carcinoma (SCC) and other non-small cell lung cancer while … Among primary lung cancer
patients, small cell lung cancer … ’ positive rate than non-small cell cancer patients (Table 3). …

… with less severe side effects is of great necessity. In clinical treatment of cancer patients,
many … has anticancer effects against different types of human tumor cells, including of ovarian …

… the treatment of small cell lung cancer (… negative regulation of interleukin-1β converting
enzyme expression 6 , an essential effector of apoptosis. A characteristic feature of cancer cells is …

… patients because research has shown that these therapeutic agents had no side effects,
or at least the side effects were much more moderate compared with that of clinical first line …

… effect of … lung cancer cells, finding that cisplatin can enhance miR-29c expression. Then,
a CCK8 assay was performed to measure the lung cancer cell viability upon cisplatin treatment …

… primary human non–small cell lung cancers (NSCLC) compared with normal lung epithelium.
We found that genetic inhibition of PKCε by expressing a dominant-negative mutant led to …

… to NSCLC cells partially through targeting lung cancer stem like cells. More importantly,
clinical experience with disulfiram in the treatment of alcoholism shows that side effects of …